PCOM2 - The Physician Communication Intervention, Version 2.0

Last updated: August 22, 2024
Sponsor: University of Colorado, Denver
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Physician Communication 2 Virtual (PCOM2-virtual)

Physician Communication Standard (PCOM-standard)

Clinical Study ID

NCT05336240
21-4870
  • Ages 9-17
  • All Genders

Study Summary

Poor quality of primary care providers' vaccine recommendations lead to low adolescent human papillomavirus vaccination rates and hundreds of thousands of adolescents unnecessarily at risk for HPV-associated cancers and diseases. Though a previous provider communication intervention, called PCOM, was found to be effective for increasing adolescent HPV vaccination in primary care, its dissemination is limited by the need for significant research team involvement to teach providers how to use the intervention's components. To address this, investigators propose to develop and test a virtual version of PCOM, use mixed methods to assess contextual factors affecting its use compared to the original PCOM intervention, and develop an optimized version of PCOM for broad dissemination to increase adolescent HPV vaccination nationally.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Parents: Have an adolescent between the ages of 9-17 years old and receivingadolescent care at an enrolled clinic

  • Providers: All providers at participating study practices will be eligible toparticipate.

Exclusion

Exclusion Criteria:

  • Parents: Does not have an adolescent between the ages of 9-17 years old and is notreceiving adolescent care at an enrolled clinic

  • Providers: Providers who are not at participating study practices

Study Design

Total Participants: 120
Treatment Group(s): 2
Primary Treatment: Physician Communication 2 Virtual (PCOM2-virtual)
Phase:
Study Start date:
November 15, 2023
Estimated Completion Date:
December 31, 2026

Study Description

The overarching goal is to develop a "Virtual" version of the PCOM intervention ("PCOM-Virtual") and compare its efficacy for increasing HPV vaccination among adolescents to that of the original PCOM intervention ("PCOM-Standard"). Using Dissemination & Implementation (D&I) science principles to develop and evaluate the PCOM-Virtual intervention for non-inferiority, investigators anticipate that to have a "shelf ready" intervention and associated "User Manual" that can be easily incorporated into practices broadly to improve the practice's adolescent HPV vaccination rates.

Specific Aims are to: (1) develop the "PCOM-Virtual" intervention using principles of D&I Science; (2) compare the efficacy of "PCOM-Virtual" versus "PCOM-Standard" in improving adolescent HPV vaccine utilization; and (3) examine whether practice, patient and provider characteristics are associated with variability in the efficacy of PCOM-Virtual and PCOM-Standard.

Connect with a study center

  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado 80045
    United States

    Active - Recruiting

  • University of Kansas Medical Center

    Wichita, Kansas 67208
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.